Long-term health-related quality-of-life outcomes after permanent prostate brachytherapy

Onkologie

Volumn 31, Issue 11, 2008, Pages 599-603

  Schäfer, Jörg W ^a   Welzel, Grit ^a   Trojan, Lutz ^a   Eppler, Nils ^a   Harrer, Katrin ^a   Michel, Maurice S ^a   Alken, Peter ^a   Wenz, Frederik ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

EORTC QLQ PR25; Health related quality of life; Permanent brachytherapy; Prostate

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRACHYTHERAPY; CLINICAL ASSESSMENT; CLINICAL FEATURE; ERECTILE DYSFUNCTION; FOLLOW UP; GERMANY; HEALTH CARE ORGANIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROSTATE ADENOCARCINOMA; QUALITY OF LIFE; QUESTIONNAIRE; RECTUM DISEASE; SEXUALITY; STRESS INCONTINENCE; UNIVERSITY HOSPITAL; URINARY TRACT DISEASE;

AGED; AGED, 80 AND OVER; BRACHYTHERAPY; COMORBIDITY; ERECTILE DYSFUNCTION; GERMANY; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PREVALENCE; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; URINARY INCONTINENCE;

EID: 58849157900     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000162270     Document Type: Article

References (34)

1. Blasko JC, Mate T, Sylvester JE, et al: Brachytherapy for carcinoma of the prostate: Techniques, patient selection, and clinical outcomes. Semin Radiat Oncol 2002;12:81-94.
2. Blasko JC, Wallner K, Grimm PD, et al: Prostate specific antigen based disease control following ultrasound guided 125jodine implantation for stage T1/T2 prostate carcinoma. J Urol 1995;154:1096-1099.
3. Block T, Czempiel H, Zimmermann F: Transperineal permanent seed implantation of 'low risk' prostate cancer. Strahlenther Onkol 2006;11:666-671.
4. Catalona WJ, Bigg SW: Nerve-sparing radical prostatectomy: Evaluation of results after 250 patients. J Urol 1990;143:538-543.
5. Galalae RM, Martinez A, Nuernberg N, et al: Hypofractionated conformal HDR brachytherapy in hormone naïve men with localized prostate cancer. Strahlenther Onkol 2006;3:135-141.
6. Gerber GS, Thisted RA, Scardino PT, et al: Results of radical prostatectomy in men with clinically localized prostate cancer. JAMA 1995;276;615-619.
7. Peschel RE, Colberg JW: Surgery, brachytherapy, and external beam radiotherapy for early prostate cancer. Lancet Oncol 2003;4:233-241.
8. Feigenberg SJ, Lee WR, Desilvio ML, et al: Health-related quality of life in men receiving prostate brachytherapy on RTOG 98-05. Int J Radiat Oncol 2005;62:956-964.
9. Pinkava M, Fischedick K, Piroth MD, et al: Health-related quality of life after permanent interstitial brachytherapy for prostate cancer. Strahlenther Onkol 2005;11:660-665.
10. Borghede G, Sullivan M: Measurement of quality of life in localized prostatic cancer patients treated with radiotherapy. Development of a prostate cancer-specific module supplementing the EORTC QLQ-C30. Qual Life Res 1996;5:212-222.
11. Bates TS, Wright MPJ, Gillant DA: Prevalence and impact of incontinence and impotence following total prostatectomy assessed anonymously by the ICS-male questionnaire. Eur Urol 1998;33:165-169.
12. Donovan JL, Abrams P, Peters TJ, et al: The ICS-'BPH' study: the psychometric validity and reliability of the ICSmale questionnaire. Br J Urol 1996;77:554-562.
13. Nag S, Beyer D, Friedland J, Grimm P, Nath R: American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol 1999;44:789-799.
14. Nath R, Anderson LL, Luxton G, et al: Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group, 43. Med Phys 1995;22:209-234.
15. Brandeis JM, Litwin MS, Burnison CM, et al: Quality of life assessment after brachytherapy for early stage prostate cancer. J Urol 2000;163:851-857.
16. Lee WR, McQuellon RP, Case LD, et al: Early quality of life assessment in men treated with permanent source interstitial brachytherapy for clinically localized prostate cancer. J Urol 1999;162:403-406.
17. Litwin MS: Health related quality of life in older men without prostate cancer. J Urol 1999;161:1180-1184.
18. Miller DC, Sandra MG, Dunn RL, et al: Long-term outcomes among localized prostate cancer survivors: Health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. J Clin Oncol 2005;23:2772-2780.
19. Van Gellekom MP, Moerland MA, Vulpen MV, et al: Quality of life of patients after permanent prostate brachytherapy in relation to dosimetry. Int J Radiat Oncol 2005;63:772-780.
20. Merrick GS, Butler WM, Wallner KE, et al: Long-term urinary quality of life after permanent prostate brachytherapy. Cancer J 2003;10:54-60.
21. Stone NN, Stock RG: Complications following permanent prostate brachytherapy. Eur Urol 2002;41:427-433.
22. Talcott JA, Clark JA, Stark PC, Mitchell SP: Long-term treatment related complications of brachytherapy for early prostate cancer: a survey of patients previously treated. J Urol 2001;166:494-499.
23. Merrick GS, Butler WM, Wallner KE, et al: Effect of transurethral resection on urinary quality of life after permanent prostate brachytherapy. Int J Radiat Oncol 2004;58:1056-1062.
24. Grills IS, Martinez AA, Hollander M, et al: High dose rate brachytherapy as prostate cancer mono - therapy reduces toxicity to low dose rate palladium seeds. J Urol 2004;171:1098-1104.
25. Feldman HA, Goldstein I, Hatzichristou DG, et al: Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994;151:54-61.
26. Laumann EO, Paik AMA, Rosen RC: Sexual dysfunction in the United States: Prevalence and predictors. JAMA 1999;281:537-544.
27. Merrick GS, Wallner KE, Butler WM: Management of sexual dysfunction after prostate brachytherapy. Oncology 2003;17:52-62.
28. Potter L, Torre T, Fearn PA, et al: Potency after permanent prostate brachytherapy for localized prostate cancer. Int J Radiat Oncol 2001;60:1235-1242.
29. Merrick GS, Butler WM, Galbreath RW, et al: Erectile function after permanent prostate brachytherapy. Int J Radiat Oncol 2002;52:893-902.
30. Merrick GS, Wallner KE, Butler WM: Permanent interstitial brachytherapy for the management of carcinoma of the prostate gland. J Urol 2003;169:1643-1652.
31. Stock RG, Kao J, Stone NN: Penile erection function after permanent radioactive seed implantation for treatment of prostate cancer. J Urol 2001;165:436-439.
32. Zelefsky MJ, Wallner KE, Ling CC, et al: Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer. J Clin Oncol 1999;17:517-522.
33. Merrick GS, Butler WM: Rectal function following permanent prostate brachytherapy. W V Med J 2004;100:18-20.
34. Pinkava M, Gagel B, Piroth MD, et al: Changes of dose delivery distribution within the first month after permanent interstitial brachytherapy for prostate cancer. Strahlenther Onkol 2006;9:525-530.